Monte Rosa Therapeutics to Present Late-breaking Preclinical Data on Targeting GSPT1 for Myc-driven Cancers at AACR-NCI-EORTC Virtual International ConferenceGlobeNewsWire • 09/30/21
Monte Rosa Therapeutics Announces Addition to Russell 2000® and Russell 3000® IndexesGlobeNewsWire • 09/10/21
Monte Rosa Therapeutics to Participate in Morgan Stanley 19th Annual Global Healthcare ConferenceGlobeNewsWire • 09/08/21
Monte Rosa Therapeutics Reports Second Quarter 2021 Financial Results and Highlights Pipeline and Business ProgressGlobeNewsWire • 08/12/21